Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders

Haematologica

Volumn 90, Issue 2, 2005, Pages 261-262

  Randi, Maria Luigia ^a,b   Luzzatto, Guido ^a   Tezza, Fabiana ^a   Girolami, Antonio ^a   Fabris, Fabrizio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Ospedale 105   (Italy)

Author keywords

Essential thrombocythemia; Hydroxyurea; Polycythemia vera; Side effects

Indexed keywords

BUSULFAN; HYDROXYUREA;

ACUTE LEUKEMIA; ADULT; AGED; ALLERGY; ARTICLE; CANCER; CHRONIC DISEASE; CORONARY ARTERY THROMBOSIS; DEEP VEIN THROMBOSIS; ERYTHEMA; FEMALE; FEVER; HUMAN; LEG ULCER; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEGALOCYTOSIS; MYELOPROLIFERATIVE DISORDER; NAIL PIGMENTATION; OCCLUSIVE CEREBROVASCULAR DISEASE; PANCYTOPENIA; PHILADELPHIA 1 CHROMOSOME; POLYCYTHEMIA VERA; SIDE EFFECT; THROMBOCYTHEMIA; THROMBOCYTOSIS; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; BUSULFAN; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; RETROSPECTIVE STUDIES; THROMBOCYTOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 14344263978     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Cortellazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghieio F, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995;332:1132-6.
2. Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin Hematol 1986;23:177-82.
3. Berlin NI. Diagnosis and classification of polycythemias. Semin Hematol 1975;12:339-51.
4. Burns ER, Reed LJ, Wenz B. Volumetric erythrocytes macrocytosis induced by hydroxyurea. Am J Clin Pathol 1986;85:337-41.
5. Braester A, Quitt M. Hydroxyurea as a cause of drug fever. Acta Haematol 2000;104:50-1.
6. Best PJ, Daoud MS, Pittelkow MR, Petitt RM. Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med 1998; 128:29-32.
7. Murphy S, Peterson, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival and leukemic transition by treatment. Semin Hematol 1997;34:29-39.
8. Randi ML, Fabris F, Girolami A. Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents. Haematologica 1999;84:1049-50.
9. Finazzi G, Ruggeri M, Rodeghiero F, Barbui T. Second malignancies in patients with essential thrombocythemia treated with busulfan and hydroxyurea: long-term follow-up of a randomized clinical trial. Br J Haematol 2000;110:577-83.